DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,536,901 | -23.4% | 2,403,672 | -3.8% | 0.83% | -36.2% |
| Q2 2023 | $28,124,010 | +4.6% | 2,499,912 | +7.1% | 1.30% | +17.8% |
| Q1 2023 | $26,894,972 | -13.5% | 2,334,633 | -13.0% | 1.10% | -15.4% |
| Q4 2022 | $31,109,878 | -23.1% | 2,684,200 | -15.7% | 1.31% | -29.5% |
| Q3 2022 | $40,439,000 | +68.2% | 3,184,200 | -9.0% | 1.85% | +17.1% |
| Q2 2022 | $24,045,000 | -28.7% | 3,500,000 | 0.0% | 1.58% | -26.9% |
| Q1 2022 | $33,740,000 | +23.8% | 3,500,000 | +52.7% | 2.16% | +12.5% |
| Q4 2021 | $27,255,000 | – | 2,292,250 | – | 1.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |